7 research outputs found

    CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION

    No full text
    The article details the issue of malignancy caused by human papilloma virus (HPV), as well as characteristics of this virus. Its genetic stability allows for efficient prevention of this pathology through vaccination. 2 vaccines, which are approved by the FDA end EMEA for use and are registered in Russia, have been created and are successfully used for this purpose. The authors believe that the best results may be achieved by combining screening examination programmes with universal reasonable administration of scheduled voluntary vaccination of Russia’s population.Key words: human papilloma virus, HPV infection, cervical cancer, malignancies, prevention, vaccination

    CERVICAL CANCER IS NOT A CHILDREN'S ILLNESS, ISN'T IT?

    No full text
    The authors highlight the foreign authors review about the spread and peculiarities of the HPV infection and HPV'associated uterine cervix impairment in teenage girls. The interaction between HPV infection and uterine cervix impairment were described. There are also the most important prevention approaches in this issue. Key words: human papilloma virus, uterine cervix impairment, cervical cancer, screening, vaccination, teenage girls

    CERVICAL CANCER IS NOT A CHILDREN'S ILLNESS, ISN'T IT?

    No full text
    The authors highlight the foreign authors review about the spread and peculiarities of the HPV infection and HPV'associated uterine cervix impairment in teenage girls. The interaction between HPV infection and uterine cervix impairment were described. There are also the most important prevention approaches in this issue. Key words: human papilloma virus, uterine cervix impairment, cervical cancer, screening, vaccination, teenage girls

    CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION

    No full text
    The article details the issue of malignancy caused by human papilloma virus (HPV), as well as characteristics of this virus. Its genetic stability allows for efficient prevention of this pathology through vaccination. 2 vaccines, which are approved by the FDA end EMEA for use and are registered in Russia, have been created and are successfully used for this purpose. The authors believe that the best results may be achieved by combining screening examination programmes with universal reasonable administration of scheduled voluntary vaccination of Russia’s population.Key words: human papilloma virus, HPV infection, cervical cancer, malignancies, prevention, vaccination

    РАК Π¨Π•Π™ΠšΠ˜ МАВКИ - НЕ Π”Π•Π’Π‘ΠšΠΠ― Π‘ΠžΠ›Π•Π—ΠΠ¬

    No full text
    The authors highlight the foreign authors review about the spread and peculiarities of the HPV infection and HPV'associated uterine cervix impairment in teenage girls. The interaction between HPV infection and uterine cervix impairment were described. There are also the most important prevention approaches in this issue. Key words: human papilloma virus, uterine cervix impairment, cervical cancer, screening, vaccination, teenage girls.Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ ΠΈΠ·Π»ΠΎΠΆΠ΅Π½Ρ‹ систСматизированныС Π΄Π°Π½Π½Ρ‹Π΅ Π·Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½Ρ‹Ρ… Π°Π²Ρ‚ΠΎΡ€ΠΎΠ², ΠΊΠ°ΡΠ°ΡŽΡ‰ΠΈΠ΅ΡΡ распространСнности ΠΈ особСнностСй СстСствСнного тСчСния Π’ΠŸΠ§-ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ ΠΈ Π’ΠŸΠ§-ассоциированных ΠΏΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠΉ шСйки ΠΌΠ°Ρ‚ΠΊΠΈ Ρƒ Π΄Π΅Π²ΠΎΡ‡Π΅ΠΊ-подростков. ΠŸΡ€Π΅Π΄ΡΡ‚Π°Π²Π»Π΅Π½Π° взаимосвязь Π’ΠŸΠ§-ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ ΠΈ ΠΏΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠΉ шСйки ΠΌΠ°Ρ‚ΠΊΠΈ с рисковым ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ΠΌ подростков; ΠΏΡ€ΠΈΠ²Π΅Π΄Π΅Π½Ρ‹ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²Π°ΠΆΠ½Ρ‹Π΅ направлСния ΠΈΡ… ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠΈ.ΠšΠ»ΡŽΡ‡Π΅Π²Ρ‹Π΅ слова: вирус ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΡ‹ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ°, Π΄Π΅Π²ΠΎΡ‡ΠΊΠΈ-подростки, рисковоС ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅, ΠΈΠ½Ρ‚Ρ€Π°ΡΠΏΠΈΡ‚Π΅Π»ΠΈΠ°Π»ΡŒΠ½Ρ‹Π΅ пораТСния Π½ΠΈΠ·ΠΊΠΎΠΉ стСпСни (LSIL), ΠΈΠ½Ρ‚Ρ€Π°ΡΠΏΠΈΡ‚Π΅Π»ΠΈΠ°Π»ΡŒΠ½Ρ‹Π΅ пораТСния высокой стСпСни (HSIL), Ρ€Π°ΠΊ шСйки ΠΌΠ°Ρ‚ΠΊΠΈ, скрининг, вакцинация. (ΠŸΠ΅Π΄ΠΈΠ°Ρ‚Ρ€ΠΈΡ‡Π΅ΡΠΊΠ°Ρ фармакология 2009;6(3):29-35)

    ΠΠšΠ’Π£ΠΠ›Π¬ΠΠ«Π• Π’ΠžΠŸΠ ΠžΠ‘Π« ΠŸΠ ΠžΠ€Π˜Π›ΠΠšΠ’Π˜ΠšΠ˜ ΠŸΠΠŸΠ˜Π›Π›ΠžΠœΠΠ’Π˜Π Π£Π‘ΠΠžΠ™ Π˜ΠΠ€Π•ΠšΠ¦Π˜Π˜

    No full text
    The article details the issue of malignancy caused by human papilloma virus (HPV), as well as characteristics of this virus. Its genetic stability allows for efficient prevention of this pathology through vaccination. 2 vaccines, which are approved by the FDA end EMEA for use and are registered in Russia, have been created and are successfully used for this purpose. The authors believe that the best results may be achieved by combining screening examination programmes with universal reasonable administration of scheduled voluntary vaccination of Russia’s population.Key words: human papilloma virus, HPV infection, cervical cancer, malignancies, prevention, vaccination.Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ ΠΏΠΎΠ΄Ρ€ΠΎΠ±Π½ΠΎ ΠΎΡΠ²Π΅Ρ‰Π°ΡŽΡ‚ΡΡ ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΡ‹ злокачСствСнных Π½ΠΎΠ²ΠΎΠΎΠ±Ρ€Π°Π·ΠΎΠ²Π°Π½ΠΈΠΉ, Π²Ρ‹Π·Π²Π°Π½Π½Ρ‹Ρ… вирусом ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΡ‹ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ° (Π’ΠŸΠ§), Π° Ρ‚Π°ΠΊΠΆΠ΅ свойства самого вируса. Π•Π³ΠΎ гСнСтичСская ΡΡ‚Π°Π±ΠΈΠ»ΡŒΠ½ΠΎΡΡ‚ΡŒ обСспСчиваСт Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡ‚ΡŒ эффСктивной ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠΈ Π΄Π°Π½Π½ΠΎΠΉ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΏΡƒΡ‚Π΅ΠΌ Π²Π°ΠΊΡ†ΠΈΠ½Π°Ρ†ΠΈΠΈ. Для этой Ρ†Π΅Π»ΠΈ ΡƒΠΆΠ΅ созданы ΠΈ ΡƒΡΠΏΠ΅ΡˆΠ½ΠΎ ΠΏΡ€ΠΈΠΌΠ΅Π½ΡΡŽΡ‚ΡΡ 2 Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ ΠΎΠ΄ΠΎΠ±Ρ€Π΅Π½Ρ‹ ΠΊ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡŽ FDA, Π•ΠœΠ•Π ΠΈ зарСгистрированы Π² России. Авторы ΡΡ‡ΠΈΡ‚Π°ΡŽΡ‚, Ρ‡Ρ‚ΠΎ Π½Π°ΠΈΠ»ΡƒΡ‡ΡˆΠΈΡ… Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ² ΠΌΠΎΠΆΠ½ΠΎ Π΄ΠΎΡΡ‚ΠΈΡ‡ΡŒ сочСтаниСм скрининговых ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌ обслСдования с повсСмСстной Ρ€Π°Π·ΡƒΠΌΠ½ΠΎΠΉ ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠ΅ΠΉ ΠΏΠ»Π°Π½ΠΎΠ²ΠΎΠΉ Π΄ΠΎΠ±Ρ€ΠΎΠ²ΠΎΠ»ΡŒΠ½ΠΎΠΉ Π²Π°ΠΊΡ†ΠΈΠ½Π°Ρ†ΠΈΠΈ насСлСния России.ΠšΠ»ΡŽΡ‡Π΅Π²Ρ‹Π΅ слова: вирус ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΡ‹ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ°, Π’ΠŸΠ§-инфСкция, Ρ€Π°ΠΊ шСйки ΠΌΠ°Ρ‚ΠΊΠΈ, злокачСствСнныС новообразования, ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠ°, вакцинация.(ΠŸΠ΅Π΄ΠΈΠ°Ρ‚Ρ€ΠΈΡ‡Π΅ΡΠΊΠ°Ρ фармакология 2011;8(1):17-21

    Inositols: pharmacology and findings of clinical trials. Current evidence and prospects

    No full text
    Yu.E. Dobrokhotova1, O.A. Gromova2, A.S. Dukhanin1, Z.Kh. Kumykova3, E.V. Sheremetyeva4, G.I. Tabeeva3 1Pirogov Russian National Research Medical University, Moscow, Russian Federation 2Federal Research Center "Informatics and Management" of the Russian Academy of Sciences, Moscow, Russian Federation 3V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russian Federation 4National Medical Research Center of Endocrinology, Moscow, Russian Federation Alterations in reproductive functions are associated with metabolic disorders, eating habits and lifestyle. In this context, a growing body of research is currently focused on the use of various vitamins and vitamin-like substances, such as inositol, in female patients with alterations in reproductive functions and metabolic disorders. Co-administration of inositol with pathogenetic therapy can be recommended to women of reproductive age with metabolic syndrome, as an additional option for preserving fertility and activating ovarian functions in young female patients with diminished ovarian reserve. Myoinositol and D-chiroinositol are inositol stereoisomers demonstrating the highest metabolic activity. The beneficial ratio of Myoinositol (MI) to D-chiroinositol (DCI) ensures the healthy state of organs and tissues, while a misbalance or depletion of inositol levels can cause various diseases. Combination of MI and DCI in a 5:1 ratio with manganese and folic acid is an&nbsp; original non-hormonal formula designed to improve functional state of the female reproductive system as well as carbohydrate and lipid metabolism. In addition, this combination should be considered as a promising alternative for the management of metabolic disorders in perimenopausal women. Keywords: reproductive function, metabolism, inositol, myoinositol, D-chiroinositol, polycystic ovary syndrome, ovarian reserve, menopause, metabolic syndrome, manganese, folic acid. For citation: Dobrokhotova Yu.E., Gromova O.A., Dukhanin A.S. et al. Inositols: pharmacology and findings of clinical trials. Current evidence and prospects. Russian Journal of Woman and Child Health. 2022;5(4):309–319 (in Russ.). DOI: 10.32364/2618-8430-2022-5-4-309-319. <br
    corecore